002750 Kunming Longjin Pharmaceutical
- 2.17
- +0.04+1.88%
About Kunming Longjin Pharmaceutical Company
The company built its factory in 1991, and after nearly 30 years of forging ahead, it has now developed into a modern biotechnology pharmaceutical enterprise integrating research, production, supply and marketing. The company has always been engaged in R&D, production (including pharmaceutical CMO business) and sales of Chinese and Western pharmaceuticals. The company's representative products include Longjin's “injectable dengzhanhuacin, injectable fibrosis, injectable bivalirudine, injectable somatostatin, and Jinleshu” seven-flavor sugar pulse capsules. The dosage forms cover freeze-dried powder injections and oral doses. Corporate honors: Famous trademarks and invention patents in Yunnan Province, 2017 Best Process Innovation Award, 2017 Kunming Famous Brand, “Outstanding Chinese Medicine Brand Enterprise”, “China's Top 100 Traditional Chinese Medicine Enterprises”, “China's Top 100 Pharmaceutical Industry Series List”, “Yunnan Top 100 Non-public Enterprises”, “2023 Yunnan Top 100 High-tech Enterprises”, “Kunming Health Enterprise”, “Typical Case of Digital Transformation of Listed Companies in 2023”, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- xiane fan
- Chairman, Directors, Strategy Committee Convener, Member of the Remuneration and Assessment Committee
- 835.10K
- xiaonan zhou
- Vice Chairman, Directors, Audit Committee Member, Nomination Committee Members
- 638.00K
- chunyan wen
- Directors
- 72.00K
- yahe li
- Directors, Board Secretary, Member of the Strategy Committee
- 322.10K
- lijuan fan
- Directors, General Manager
- 368.60K
- lu qiu
- Directors
- 172.20K
- shuang zhang
- Independent Directors, Remuneration and Assessment Committee Convener, Audit Committee Members
- 72.00K
- hui xu
- Independent Directors, Nomination Committee Convener, Audit Committee Convener, Member of the Remuneration and Assessment Committee
- --
- lijun wei
- Independent Directors, Member of the Strategy Committee, Nomination Committee Members
- --
- bo ning
- Securities Affairs Representative
- --
- ping liu
- Chairman of the Supervisory Board, Employee Supervisors
- 189.40K
- tong wang
- Auditors
- 36.00K
- wei zhang
- Deputy General Manager
- 560.00K
- hongbo zhang
- Deputy General Manager
- 261.00K
- ruixian yang
- Deputy General Manager
- 279.00K
- xiwen qian
- Chief Financial Officer
- 35.70K
- yong long
- Head of Audit Department
- --
- minjuan su
- Employee Representative Supervisor
- 234.80K
Analysis
Price Target
No Data
No Data